Sean A. McCarthy
2020
In 2020, Sean A. McCarthy earned a total compensation of $2.8M as Chief Executive Officer and Chairman of the Board of Directors at CytomX Therapeutics, a 24% decrease compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $357,000 |
|---|---|
| Option Awards | $1,892,850 |
| Salary | $595,000 |
| Other | $5,000 |
| Total | $2,849,850 |
McCarthy received $1.9M in option awards, accounting for 66% of the total pay in 2020.
McCarthy also received $357K in non-equity incentive plan, $595K in salary and $5K in other compensation.
Rankings
In 2020, Sean A. McCarthy's compensation ranked 4,054th out of 13,090 executives tracked by ExecPay. In other words, McCarthy earned more than 69.0% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 4,054 out of 13,090 | 69th |
Division Manufacturing | 1,635 out of 5,621 | 71st |
Major group Chemicals And Allied Products | 628 out of 2,254 | 72nd |
Industry group Drugs | 540 out of 1,954 | 72nd |
Industry Pharmaceutical Preparations | 413 out of 1,459 | 72nd |
Source: SEC filing on April 27, 2022.
McCarthy's colleagues
We found four more compensation records of executives who worked with Sean A. McCarthy at CytomX Therapeutics in 2020.